Coronavirus non-structural protein 16

Evasion, attenuation, and possible treatments

Vineet Menachery, Kari Debbink, Ralph S. Baric

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

The recent emergence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV), nearly a decade after the Severe Acute Respiratory Syndrome (SARS) CoV, highlights the importance of understanding and developing therapeutic treatment for current and emergent CoVs. This manuscript explores the role of NSP16, a 2'O-methyl-transferase (2'O-MTase), in CoV infection and the host immune response. The review highlights conserved motifs, required interaction partners, as well as the attenuation of NSP16 mutants, and restoration of these mutants in specific immune knockouts. Importantly, the work also identifies a number of approaches to exploit this understanding for therapeutic treatment and the data clearly illustrate the importance of NSP16 2'O-MTase activity for CoV infection and pathogenesis.

Original languageEnglish (US)
Pages (from-to)191-199
Number of pages9
JournalVirus Research
Volume194
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Coronavirus
Transferases
Severe Acute Respiratory Syndrome
Infection
Proteins
Therapeutics
Middle East Respiratory Syndrome Coronavirus

Keywords

  • 2'O-Methyl-transferase
  • 2'O-MTase
  • CoV
  • MDA5
  • NSP16
  • SARS-CoV

ASJC Scopus subject areas

  • Cancer Research
  • Virology
  • Infectious Diseases

Cite this

Coronavirus non-structural protein 16 : Evasion, attenuation, and possible treatments. / Menachery, Vineet; Debbink, Kari; Baric, Ralph S.

In: Virus Research, Vol. 194, 01.01.2014, p. 191-199.

Research output: Contribution to journalReview article

@article{7aa5b19de5cb48b49ca48cb826a67499,
title = "Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments",
abstract = "The recent emergence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV), nearly a decade after the Severe Acute Respiratory Syndrome (SARS) CoV, highlights the importance of understanding and developing therapeutic treatment for current and emergent CoVs. This manuscript explores the role of NSP16, a 2'O-methyl-transferase (2'O-MTase), in CoV infection and the host immune response. The review highlights conserved motifs, required interaction partners, as well as the attenuation of NSP16 mutants, and restoration of these mutants in specific immune knockouts. Importantly, the work also identifies a number of approaches to exploit this understanding for therapeutic treatment and the data clearly illustrate the importance of NSP16 2'O-MTase activity for CoV infection and pathogenesis.",
keywords = "2'O-Methyl-transferase, 2'O-MTase, CoV, MDA5, NSP16, SARS-CoV",
author = "Vineet Menachery and Kari Debbink and Baric, {Ralph S.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.virusres.2014.09.009",
language = "English (US)",
volume = "194",
pages = "191--199",
journal = "Virus Research",
issn = "0168-1702",
publisher = "Elsevier",

}

TY - JOUR

T1 - Coronavirus non-structural protein 16

T2 - Evasion, attenuation, and possible treatments

AU - Menachery, Vineet

AU - Debbink, Kari

AU - Baric, Ralph S.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The recent emergence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV), nearly a decade after the Severe Acute Respiratory Syndrome (SARS) CoV, highlights the importance of understanding and developing therapeutic treatment for current and emergent CoVs. This manuscript explores the role of NSP16, a 2'O-methyl-transferase (2'O-MTase), in CoV infection and the host immune response. The review highlights conserved motifs, required interaction partners, as well as the attenuation of NSP16 mutants, and restoration of these mutants in specific immune knockouts. Importantly, the work also identifies a number of approaches to exploit this understanding for therapeutic treatment and the data clearly illustrate the importance of NSP16 2'O-MTase activity for CoV infection and pathogenesis.

AB - The recent emergence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV), nearly a decade after the Severe Acute Respiratory Syndrome (SARS) CoV, highlights the importance of understanding and developing therapeutic treatment for current and emergent CoVs. This manuscript explores the role of NSP16, a 2'O-methyl-transferase (2'O-MTase), in CoV infection and the host immune response. The review highlights conserved motifs, required interaction partners, as well as the attenuation of NSP16 mutants, and restoration of these mutants in specific immune knockouts. Importantly, the work also identifies a number of approaches to exploit this understanding for therapeutic treatment and the data clearly illustrate the importance of NSP16 2'O-MTase activity for CoV infection and pathogenesis.

KW - 2'O-Methyl-transferase

KW - 2'O-MTase

KW - CoV

KW - MDA5

KW - NSP16

KW - SARS-CoV

UR - http://www.scopus.com/inward/record.url?scp=84920574962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920574962&partnerID=8YFLogxK

U2 - 10.1016/j.virusres.2014.09.009

DO - 10.1016/j.virusres.2014.09.009

M3 - Review article

VL - 194

SP - 191

EP - 199

JO - Virus Research

JF - Virus Research

SN - 0168-1702

ER -